Skip to content
lifestyle.floredechampagne.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Alvotech
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
August 21, 2026
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
August 20, 2026
Alvotech to Report Financial Results for H1 2026
August 19, 2026
Alvotech announces successful closure of FDA inspection of manufacturing facility
August 18, 2026
Main Results of 2026 Annual and Extraordinary General Meeting
June 3, 2026
Alvotech to present at upcoming investor conferences in June
June 2, 2026
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
May 11, 2026
Alvotech Q1 2026 Financial Results
May 6, 2026
Alvotech Announces a Change in its Executive Team
April 30, 2026
Alvotech to Report Financial Results for the First Quarter of 2026
April 24, 2026
1
2
Next Page
→